Indications: The Edwards SAPIEN 3, SAPIEN 3 Ultra, and SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve system is indicated for relief of aortic stenosis in patients with symptomatic heart …

The Edwards SAPIEN 3, SAPIEN 3 Ultra, and SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve system is indicated for patients with symptomatic heart disease due to failing (stenosed, …

The present assessment of long-term outcomes in intermediate-risk patients who underwent TAVR with the S3 balloon-expandable valve system is paralleled by recently published 5-year …

2021年8月26日 · The key findings are that (1) in a large, unselected, real-world population, TAVR with the Ultra THV was associated with excellent procedural outcomes and a low complication …

2024年11月24日 · On the basis of real-world data, TAVR with the S3UR is associated with superior 1-year clinical and echocardiographic outcomes than its predecessors, the S3 and …

Controlled, low-profile vascular access for today's transcatheter aortic valve patients. Thoughtfully designed to: *TAVI = Transcatheter Aortic Valve Implantation. 1. Nazif,et al. Real-World …

In this single-center, observational study, Rheude et al. identified 1,328 consecutive patients who underwent transfemoral TAVR with these 2 devices from 2014 to 2020, and to control for …

The Edwards SAPIEN 3 Ultra transcatheter heart valve system is indicated for relief of aortic stenosis in patients with symptomatic heart disease due to severe native calcific aortic …

2023年11月21日 · Our aim was to assess the feasibility of repeat transcatheter aortic valve (TAV) replacement for degenerated Sapien3 (S3) prostheses by simulating subsequent implantation …

symptomatic aortic stenosis treated with transcatheter aortic valve replacement (TAVR) in comparison to medical management in high surgical risk or inoperable patients1. The third …